10.74

0.28% -0.03

After Hours: 10.84 0.10 +0.93%

Helix Acquisition Corp Ii (HLXB)

Overview News Price History Discussions Forecast

Helix Acquisition Corp Ii stock is traded at $10.74, with a volume of 1,933. It is down -0.28% in the last 24 hours and down -0.28% over the past month. Helix Acquisition Corp II is a Blank check company.

Previous Close:

$10.77

Open:

$10.7

24h Volume:

1,933

Relative Volume:

0.04

Market Cap:

$253.19M

Revenue:

Net Income/Loss:

$3.27M

P/E Ratio:

63.97

EPS:

0.1679

Net Cash Flow:

$-647.10K

1W Performance:

-1.38%

1M Performance:

-0.28%

6M Performance:

+3.77%

1Y Performance:

+4.78%

1-Day Range:

$10.70

$10.74

1-Week Range:

$10.60

$10.87

52-Week Range:

$10.14

$11.59

Helix Acquisition Corp Ii Stock (HLXB) Company Profile

Name

Helix Acquisition Corp Ii

Sector

Financial (5001)

Industry

Shell Companies (110)

Phone

857 702 0377

Address

C/O CORMORANT ASSET MANAGEMENT, LP, BOSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

HLXB's Discussions on Twitter

Compare HLXB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HLXB Helix Acquisition Corp Ii	10.74	253.19M	0	3.27M	-647.10K	0.1679
LION Lionsgate Studios Corp	6.52	1.86B	3.13B	50.80M	555.00M	0.1772
AACT Ares Acquisition Corporation Ii	11.23	697.50M	0	16.92M	-1.35M	0.29
ANSC Agriculture Natural Solutions Acquisition Corp	10.67	461.01M	0	1.30M	0	0.0301
EQV Eqv Ventures Acquisition Corp	10.09	449.29M	0	0	0	0.00
NETD Nabors Energy Transition Corp Ii	11.02	418.99M	0	14.95M	0	0.4068

Helix Acquisition Corp Ii Stock (HLXB) Latest News

Apr 20, 2025

Harraden Circle Investments LLC Takes Position in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat

Apr 20, 2025

Apr 01, 2025

MLTX stock touches 52-week low at $36.51 amid market shifts - Investing.com Australia

Apr 01, 2025

MLTX stock touches 52-week low at $36.51 amid market shifts By Investing.com - Investing.com South Africa

Apr 01, 2025

BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors - Business Wire

Apr 01, 2025

Mar 27, 2025

Firm foundations: Can US IPO markets continue to build on solid gains? - Lexology

Mar 27, 2025

Mar 23, 2025

Decagon Asset Management LLP Invests $1.96 Million in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat

Mar 23, 2025

Mar 20, 2025

Newsroom - White & Case LLP

Mar 20, 2025

Mar 18, 2025

GSK’s $1.15B Idrx buyout leads slow M&A market as deals stay strong - BioWorld Online

Mar 18, 2025

Mar 14, 2025

Bay Area VC-funded life sciences companies raised over $5 billion in 2024 - The Business Journals

Mar 14, 2025

Mar 12, 2025

Helix Exploration expands with key acquisition at Rudyard - Proactive Investors

Mar 12, 2025

Mar 11, 2025

Helix Acquisition Corp. II SEC 10-K Report - TradingView

Mar 11, 2025

Mar 10, 2025

MLTX stock touches 52-week low at $37.53 amid market shifts - Investing.com Australia

Mar 10, 2025

BBIOBridgebio Pharma Latest Stock News & Market Updates - StockTitan

Mar 10, 2025

Mar 06, 2025

Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics - Global Legal Chronicle

Mar 06, 2025

Mar 04, 2025

BridgeBio Oncology and Helix enter definitive merger agreement - MSN

Mar 04, 2025

Mar 03, 2025

BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter

Mar 03, 2025

White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics - White & Case LLP

Mar 03, 2025

Feb 28, 2025